Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-19 17:38:56 UTC |
---|
Updated at | 2021-06-29 23:50:35 UTC |
---|
NP-MRD ID | NP0025556 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Macrolactin A |
---|
Provided By | JEOL Database |
---|
Description | Macrolactin A is found in Bacillus sp. PP19-H3. It was first documented in 2015 (PMID: 26544726). Based on a literature review very few articles have been published on (3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one (PMID: 27071303) (PMID: 27792158) (PMID: 33808737) (PMID: 33184304) (PMID: 32944805) (PMID: 32673673). |
---|
Structure | [H]O[C@]1([H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])[C@]([H])(O[H])C([H])([H])[C@@]([H])(O[H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])C([H])([H])C([H])([H])[C@]([H])(OC(=O)\C([H])=C(\[H])/C(/[H])=C([H])\C1([H])[H])C([H])([H])[H] InChI=1S/C24H34O5/c1-20-13-7-3-2-4-8-16-22(26)19-23(27)17-11-5-9-14-21(25)15-10-6-12-18-24(28)29-20/h2,4-6,8-12,14,16,18,20-23,25-27H,3,7,13,15,17,19H2,1H3/b4-2-,10-6-,11-5-,14-9-,16-8-,18-12-/t20-,21-,22+,23+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C24H34O5 |
---|
Average Mass | 402.5310 Da |
---|
Monoisotopic Mass | 402.24062 Da |
---|
IUPAC Name | (3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one |
---|
Traditional Name | (3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]O[C@]1([H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])[C@]([H])(O[H])C([H])([H])[C@@]([H])(O[H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])C([H])([H])C([H])([H])[C@]([H])(OC(=O)\C([H])=C(\[H])/C(/[H])=C([H])\C1([H])[H])C([H])([H])[H] |
---|
InChI Identifier | InChI=1S/C24H34O5/c1-20-13-7-3-2-4-8-16-22(26)19-23(27)17-11-5-9-14-21(25)15-10-6-12-18-24(28)29-20/h2,4-6,8-12,14,16,18,20-23,25-27H,3,7,13,15,17,19H2,1H3/b4-2-,10-6-,11-5-,14-9-,16-8-,18-12-/t20-,21-,22+,23+/m1/s1 |
---|
InChI Key | XXDIJWSZFWZBRM-CJPCAZISSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, C5D5N, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
Bacillus sp. PP19-H3 | JEOL database | - Nagao, T., et al, J. Antibiotics 54, 333 (2001)
|
|
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Li W, Tang XX, Yan X, Wu Z, Yi ZW, Fang MJ, Su X, Qiu YK: A new macrolactin antibiotic from deep sea-derived bacteria Bacillus subtilis B5. Nat Prod Res. 2016 Dec;30(24):2777-2782. doi: 10.1080/14786419.2016.1155576. Epub 2016 Apr 13. [PubMed:27071303 ]
- Yan X, Zhou YX, Tang XX, Liu XX, Yi ZW, Fang MJ, Wu Z, Jiang FQ, Qiu YK: Macrolactins from Marine-Derived Bacillus subtilis B5 Bacteria as Inhibitors of Inducible Nitric Oxide and Cytokines Expression. Mar Drugs. 2016 Oct 26;14(11). pii: md14110195. doi: 10.3390/md14110195. [PubMed:27792158 ]
- Fakhri S, Yarmohammadi A, Yarmohammadi M, Farzaei MH, Echeverria J: Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection. Mar Drugs. 2021 Mar 19;19(3). pii: md19030165. doi: 10.3390/md19030165. [PubMed:33808737 ]
- Riyanti, Balansa W, Liu Y, Sharma A, Mihajlovic S, Hartwig C, Leis B, Rieuwpassa FJ, Ijong FG, Wagele H, Konig GM, Schaberle TF: Selection of sponge-associated bacteria with high potential for the production of antibacterial compounds. Sci Rep. 2020 Nov 12;10(1):19614. doi: 10.1038/s41598-020-76256-2. [PubMed:33184304 ]
- Salazar F, Ortiz A, Sansinenea E: A Strong Antifungal Activity of 7-O-Succinyl Macrolactin A vs Macrolactin A from Bacillus amyloliquefaciens ELI149. Curr Microbiol. 2020 Nov;77(11):3409-3413. doi: 10.1007/s00284-020-02200-2. Epub 2020 Sep 17. [PubMed:32944805 ]
- Sapkota M, Gao M, Li L, Yang M, Shrestha SK, Choi H, Soh Y: Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling. Eur J Pharmacol. 2020 Sep 15;883:173305. doi: 10.1016/j.ejphar.2020.173305. Epub 2020 Jul 14. [PubMed:32673673 ]
- Kim EN, Gao M, Choi H, Jeong GS: Marine Microorganism-Derived Macrolactins Inhibit Inflammatory Mediator Effects in LPS-Induced Macrophage and Microglial Cells by Regulating BACH1 and HO-1/Nrf2 Signals through Inhibition of TLR4 Activation. Molecules. 2020 Feb 4;25(3). pii: molecules25030656. doi: 10.3390/molecules25030656. [PubMed:32033079 ]
- Helaly SE, Hamad Z, El Sayed MA, Abdel-Motaal FF, Nassar MI, Ito SI, Stadler M: Bacillus methylotrophicus ASWU-C2, a strain inhabiting hot desert soil, a new source for antibacterial bacillopyrone, pyrophen, and cyclopeptides. Z Naturforsch C J Biosci. 2018 Dec 19;74(1-2):55-59. doi: 10.1515/znc-2018-0093. [PubMed:30864389 ]
- Chen L, Heng J, Qin S, Bian K: A comprehensive understanding of the biocontrol potential of Bacillus velezensis LM2303 against Fusarium head blight. PLoS One. 2018 Jun 1;13(6):e0198560. doi: 10.1371/journal.pone.0198560. eCollection 2018. [PubMed:29856856 ]
- Liu Q, Ren P, Liu Y, Qin W, Li H, Li W: Exploration of the Glycosyltransferase BmmGT1 from a Marine-Derived Bacillus Strain as a Potential Enzyme Tool for Compound Glycol-Diversification. J Microbiol Biotechnol. 2018 Jun 28;28(6):931-937. doi: 10.4014/jmb.1802.02008. [PubMed:29847868 ]
- Jin J, Hwang K, Joo JD, Han JH, Kim CY: Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma. Oncotarget. 2017 Dec 14;9(2):2140-2147. doi: 10.18632/oncotarget.23295. eCollection 2018 Jan 5. [PubMed:29416760 ]
- Jin J, Choi SH, Lee JE, Joo JD, Han JH, Park SY, Kim CY: Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model. Oncol Lett. 2017 May;13(5):3767-3773. doi: 10.3892/ol.2017.5918. Epub 2017 Mar 27. [PubMed:28529591 ]
- Souris C, Misale A, Chen Y, Luparia M, Maulide N: From Stereodefined Cyclobutenes to Dienes: Total Syntheses of Ieodomycin D and the Southern Fragment of Macrolactin A. Org Lett. 2015 Sep 18;17(18):4486-9. doi: 10.1021/acs.orglett.5b02149. Epub 2015 Sep 9. [PubMed:26349917 ]
- Noh K, Kang PsiW: Calculation of a First-In-Man Dose of 7-O-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs. Biomol Ther (Seoul). 2017 Nov 1;25(6):648-658. doi: 10.4062/biomolther.2016.192. [PubMed:28274094 ]
- Regmi SC, Park SY, Kim SJ, Banskota S, Shah S, Kim DH, Kim JA: The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the beta-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt. PLoS One. 2015 Nov 6;10(11):e0141753. doi: 10.1371/journal.pone.0141753. eCollection 2015. [PubMed:26544726 ]
- Nagao, T., et al. (2001). Nagao, T., et al, J. Antibiotics 54, 333 (2001). J. Antibiotics.
|
---|